Birgitta Versluijs

175 Discussion References 1. Vande Vusse LK, Madtes DK. Early Onset Noninfectious Pulmonary Syndromes after Hematopoietic Cell Transplanta- tion. Clin Chest Med. 2017;38(2):233-48. 2. Radhakrishnan SV, Hildebrandt GC. A call to arms: a critical need for interven- tions to limit pulmonary toxicity in the stem cell transplantation patient popu- lation. Current hematologic malignancy reports. 2015;10(1):8-17. 3. Gronningsaeter IS, Tsykunova G, Lil- leeng K, Ahmed AB, Bruserud O, Reik- vam H. Bronchiolitis obliterans syndro- me in adults after allogeneic stem cell transplantation-pathophysiology, diag- nostics and treatment. Expert review of clinical immunology. 2017;13(6):553-69. 4. Bergeron A. Late-Onset Noninfectious Pulmonary Complications After Allogen- eic Hematopoietic Stem Cell Transplan- tation. Clin Chest Med. 2017;38(2):249- 62. 5. Versluys AB, Rossen JW, van Ewijk B, Schuurman R, Bierings MB, Boelens JJ. Strong association between respiratory viral infection early after hematopoie- tic stem cell transplantation and the development of life-threatening acute and chronic alloimmune lung syndro- mes. Biol Blood Marrow Transplant. 2010;16(6):782-91. 6. Versluys B, Bierings M, Murk JL, Wolfs T, Lindemans C, Vd Ent K, et al. Infec- tion with a respiratory virus before he- matopoietic cell transplantation is asso- ciated with alloimmune-mediated lung syndromes. The Journal of allergy and clinical immunology. 2017. 7. Keates-Baleeiro J, Moore P, Koyama T, Manes B, Calder C, Frangoul H. Inci- dence and outcome of idiopathic pneu- monia syndrome in pediatric stem cell transplant recipients. Bone Marrow Transplant. 2006;38(4):285-9. 8. Sano H, Kobayashi R, Iguchi A, Suzuki D, Kishimoto K, Yasuda K, et al. Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoie- tic SCT in children. Bone Marrow Trans- plant. 2014;49(1):38-41. 9. Park M, Koh KN, Kim BE, Im HJ, Seo JJ. Clinical features of late onset non-in- fectious pulmonary complications follo- wing pediatric allogeneic hematopoietic stem cell transplantation. Clinical trans- plantation. 2011;25(2):E168-76. 10. Nishio N, Yagasaki H, Takahashi Y, Mu- ramatsu H, Hama A, Tanaka M, et al. Late-onset non-infectious pulmonary complications following allogeneic he- matopoietic stem cell transplantation in children. Bone Marrow Transplant. 2009;44(5):303-8. 11. Nagasawa M, Mitsuiki N, Aoki Y, Ono T, Isoda T, Imai K, et al. Effect of redu- ced-intensity conditioning and the risk of late-onset non-infectious pulmonary complications in pediatric patients. European journal of haematology. 2017;99(6):525-31. 12. Madanat-Harjuoja LM, Valjento S, Vet- tenranta K, Kajosaari M, Dyba T, Taski- nen M. Pulmonary function following allogeneic stem cell transplantation in childhood: a retrospective cohort study of 51 patients. Pediatric transplantation. 2014;18(6):617-24. 13. Duncan CN, Buonanno MR, Barry EV, Myers K, Peritz D, Lehmann L. Bron- chiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation. Bone Marrow Trans- plant. 2008;41(11):971-5. 14. Abugideiri M, Nanda RH, Butker C, Zhang C, Kim S, Chiang KY, et al. Fac- tors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic He- matopoietic Stem Cell Transplantation 9